Science & Technology EMBL Heidelberg researchers compared the effect of drugs on isolated bacteria versus those growing in communities. This is the first study showing that bacteria are more resilient when in community due to cross-protection strategies. This could help researchers design more efficient therapies.
2024
science-technology
Science & Technology Study shows that gut bacteria can metabolise carcinogens and cause them to accumulate in distant organs, leading to tumour development.
2024
science-technology
EMBL AnnouncementsLab Matters Three EMBL scientists received this year’s ERC Starting Grants, and will be awarded €1.5 million over five years to carry out research projects.
2022
embl-announcementslab-matters
Science & Technology A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
2021
sciencescience-technology
ConnectionsLab Matters The EMBL Imaging Centre is preparing for external user access, after an on-time and on-budget build and handover to the science team.
2021
connectionslab-matters
Lab MattersPeople & Perspectives EMBL Director Matthias Hentze describes the Environmental Research Initiative: a community effort to solve global environmental challenges.
2021
lab-matterspeople-perspectives
EMBL AnnouncementsLab Matters The Gesellschaft für Biochemie und Molekularbiologie has awarded a FEBS Anniversary Prize to Michael Zimmermann for his gut microbiome research.
2021
embl-announcementslab-matters
People & Perspectives Michael Zimmermann's group will investigate how gut microbes affect the body’s response to drugs.
2019
people-perspectivesscience
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive
